A Bristol Tennessee Based Drug Manufacturer Is Reporting A Strong Third Quarter. King Pharmaceuticals Said Total Revenues Were 463 Million Dollars, Compared To 388 Million Dollars For The Same Period Of 2008. Company Officials Said The 19 Percent Increase In Total Revenues From Last Year Was Primarily Due To Branded Pharmaceutical And Animal Health Sales As The Result Of The Alpharma Acquisition. Net Income For The Third Quarter Of 2009 Was 42 Million Dollars And Diluted Earnings Per Share Of 17 Cents.